BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27926780)

  • 1. Newly translated proteins are substrates for ubiquitin, ISG15, and FAT10.
    Spinnenhirn V; Bitzer A; Aichem A; Groettrup M
    FEBS Lett; 2017 Jan; 591(1):186-195. PubMed ID: 27926780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for an involvement of the ubiquitin-like modifier ISG15 in MHC class I antigen presentation.
    Held T; Basler M; Knobeloch KP; Groettrup M
    Eur J Immunol; 2021 Jan; 51(1):138-150. PubMed ID: 32686110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation.
    Aichem A; Anders S; Catone N; Rößler P; Stotz S; Berg A; Schwab R; Scheuermann S; Bialas J; Schütz-Stoffregen MC; Schmidtke G; Peter C; Groettrup M; Wiesner S
    Nat Commun; 2018 Aug; 9(1):3321. PubMed ID: 30127417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation.
    Aichem A; Kalveram B; Spinnenhirn V; Kluge K; Catone N; Johansen T; Groettrup M
    J Cell Sci; 2012 Oct; 125(Pt 19):4576-85. PubMed ID: 22797925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasis.
    Fan JB; Arimoto K; Motamedchaboki K; Yan M; Wolf DA; Zhang DE
    Sci Rep; 2015 Jul; 5():12704. PubMed ID: 26226047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ubiquitin-like modifier FAT10 inhibits retinal PDE6 activity and mediates its proteasomal degradation.
    Boehm AN; Bialas J; Catone N; Sacristan-Reviriego A; van der Spuy J; Groettrup M; Aichem A
    J Biol Chem; 2020 Oct; 295(42):14402-14418. PubMed ID: 32817338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAT10ylation as a signal for proteasomal degradation.
    Schmidtke G; Aichem A; Groettrup M
    Biochim Biophys Acta; 2014 Jan; 1843(1):97-102. PubMed ID: 23333871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAT10, a ubiquitin-independent signal for proteasomal degradation.
    Hipp MS; Kalveram B; Raasi S; Groettrup M; Schmidtke G
    Mol Cell Biol; 2005 May; 25(9):3483-91. PubMed ID: 15831455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAT10 : Activated by UBA6 and Functioning in Protein Degradation.
    Pelzer C; Groettrup M
    Subcell Biochem; 2010; 54():238-46. PubMed ID: 21222287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
    Bialas J; Groettrup M; Aichem A
    PLoS One; 2015; 10(3):e0120329. PubMed ID: 25768649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10.
    Schmidtke G; Kalveram B; Weber E; Bochtler P; Lukasiak S; Hipp MS; Groettrup M
    J Biol Chem; 2006 Jul; 281(29):20045-54. PubMed ID: 16707496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.
    Bialas J; Boehm AN; Catone N; Aichem A; Groettrup M
    J Biol Chem; 2019 Mar; 294(12):4315-4330. PubMed ID: 30718280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.
    Aichem A; Pelzer C; Lukasiak S; Kalveram B; Sheppard PW; Rani N; Schmidtke G; Groettrup M
    Nat Commun; 2010 May; 1():13. PubMed ID: 20975683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
    Aichem A; Sailer C; Ryu S; Catone N; Stankovic-Valentin N; Schmidtke G; Melchior F; Stengel F; Groettrup M
    Nat Commun; 2019 Oct; 10(1):4452. PubMed ID: 31575873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15.
    Durfee LA; Lyon N; Seo K; Huibregtse JM
    Mol Cell; 2010 Jun; 38(5):722-32. PubMed ID: 20542004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin-like modifier FAT10 covalently modifies HUWE1 and strengthens the interaction of AMBRA1 and HUWE1.
    Mueller S; Bialas J; Ryu S; Catone N; Aichem A
    PLoS One; 2023; 18(8):e0290002. PubMed ID: 37578983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon.
    Xu D; Zhang T; Xiao J; Zhu K; Wei R; Wu Z; Meng H; Li Y; Yuan J
    Autophagy; 2015 Apr; 11(4):617-28. PubMed ID: 25906440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Link between the ubiquitin conjugation system and the ISG15 conjugation system: ISG15 conjugation to the UbcH6 ubiquitin E2 enzyme.
    Takeuchi T; Iwahara S; Saeki Y; Sasajima H; Yokosawa H
    J Biochem; 2005 Dec; 138(6):711-9. PubMed ID: 16428300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ISG15 conjugation system.
    Durfee LA; Huibregtse JM
    Methods Mol Biol; 2012; 832():141-9. PubMed ID: 22350882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Nedd8-associated polypeptides: a model for deciphering the pathway for ubiquitin-like modifications.
    Norman JA; Shiekhattar R
    Biochemistry; 2006 Mar; 45(9):3014-9. PubMed ID: 16503656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.